Author: [AUTHOR] Published on 7/1/2020 12:00:00 AM
Malek Okour, PhD, Manager, GlaxoSmithKline, Bala Cynwyd, Pennsylvania
Dr. Okour learned about ASCPT during his PhD program at the University of Minnesota. He recognized ASCPT as a major Society concerned with advancing translational science and clinical pharmacology. After years of being an ASCPT member, he went on to become an Early Career Committee member. He has recently been appointed to the Webinar Committee. He credits his PhD advisor, Richard Brundage, with referring him to ASCPT.
There are several different aspects of ASCPT that Dr. Okour enjoys. The first that comes to mind is the journal family that provides a wide range of relevant topics and tutorials. The journals are a great source of information of new topics, new methods, and updates related to the field. He also enjoys the periodic webinars as they are a direct way of presenting updates and summary of knowledge for experienced and early‐career people. He also feels that ASCPT has helped him by providing resources and platforms for knowledge on topics related to the field. The journals, webinars, and Annual Meeting have greatly advanced the transfer of knowledge between scientists through this platform for great discussions.
For the younger generation of scientists, Dr. Okour has this advice: "I recommend everyone in their early career in the field to get involved with ASCPT." He explains that ASCPT is a welcoming organization which provides tremendously helpful resources that can support their professional growth.
Now, Dr. Okour works at GSK as a manager of clinical pharmacology modeling and simulation. In his work he is involved with the design and interpretation of clinical pharmacology studies related to predicting human dose range, characterizing dose–response relationship, and justifying dose recommendations for special populations. Furthermore, he is also involved in developing mathematical models to understand disease progression, pharmacokinetics, and pharmacodynamics, and then translate these finding to efficiently guide drug development to treat diseases.
Dr. Okour has been a member of ASCPT since 2018.